Dermus financials
A multi-period view of the public annual-account figures reported for Dermus, with comparable measures and links to available source documents.
Company overviewRegistry number
0632690814
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Dermus
2025 versus 2024
- Operating line
- €171,458
- EBITDA
- -€21,417
- Total assets
- €134,373
- Equity
- €13,292
+200.7%
-227.2%
+48.9%
-67.5%
EBITDA margin -12.5% · Equity ratio +9.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €171,458 | -€21,417 | €134,373 | €13,292 | - |
| 202431 Dec 2024 | €57,011 | €16,833 | €90,238 | €40,915 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.